T. Rowe Price Associates
MURA

T. Rowe Price Associates’s Mural Oncology MURA Stock Holding History

T. Rowe Price Associates’s Portfolio MURA Stock Details MURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-26,905
Closed -$34K – 3117
2025
Q1 		$34K Hold
26,905
– – ﹤0.01% 2970
2024
Q4 		$87K Sell
26,905
-10,769
-29% -$38K ﹤0.01% 2859
2024
Q3 		$118K Hold
37,674
– – ﹤0.01% 2791
2024
Q2 		$119K Sell
37,674
-3,918
-9% -$14.4K ﹤0.01% 2724
2024
Q1 		$204K Buy
41,592
+15,600
+60% +$75.7K ﹤0.01% 2618
2023
Q4 		$154K Buy
+25,992
New +$105K ﹤0.01% 2620

Other funds holding MURA

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates's MURA Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Mural Oncology (MURA) in Q2 2025, closing a stake of 26,905 shares — an estimated $34K sold.

T. Rowe Price Associates first reported a position in MURA in Q4 2023 and held it in 6 quarters. The position peaked at $204K in Q1 2024. 66 funds tracked by Wall St. Rank hold MURA as of Q2 2025.

  • T. Rowe Price Associates reported no remaining Mural Oncology position as of Q2 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 26,905 Mural Oncology shares in Q2 2025, an estimated $34K.
  • T. Rowe Price Associates first reported a position in Mural Oncology in Q4 2023 and held it in 6 quarters.
  • T. Rowe Price Associates's Mural Oncology position peaked at $204K in Q1 2024.
  • 66 funds tracked by Wall St. Rank held Mural Oncology as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.